InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-08 | 2026-04-10 | Feldschuh Michael Richard | Director & Chief Executive Officer | Purchase | 1,000 | $9.07 | $9K | 213.7K | View ↗ | |
| 2026-03-31 | 2026-03-31 | Michel Robert J | Chief Financial Officer | Purchase | 1,000 | $9.90 | $10K | 21.1K | View ↗ | |
| 2026-03-20 | 2026-03-24 | Jefferies John | Chief Medical Officer | Purchase | 5,941 | $0.00 | — | 23.6K | View ↗ |
No financial data available for DXR.
Company may not file with SEC or CIK is unresolved.
Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis
Dynamic announces April 2026 cash distributions for Dynamic Active ETFs and ETF Series
Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center
Daxor’s Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026